IRIS
VIALE, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 702
AS - Asia 450
NA - Nord America 432
Continente sconosciuto - Info sul continente non disponibili 74
SA - Sud America 48
AF - Africa 4
Totale 1.710
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 490
US - Stati Uniti d'America 402
SG - Singapore 176
CN - Cina 138
IT - Italia 116
BR - Brasile 40
HK - Hong Kong 39
BD - Bangladesh 37
VN - Vietnam 31
DE - Germania 25
FR - Francia 21
CA - Canada 16
GB - Regno Unito 14
FI - Finlandia 10
IN - India 10
NL - Olanda 10
MX - Messico 5
AT - Austria 4
JP - Giappone 4
CR - Costa Rica 3
ES - Italia 3
PL - Polonia 3
CO - Colombia 2
EC - Ecuador 2
HN - Honduras 2
ID - Indonesia 2
IQ - Iraq 2
KG - Kirghizistan 2
UA - Ucraina 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
PT - Portogallo 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
TN - Tunisia 1
TR - Turchia 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 1.637
Salva come PNG Salva come JPEG
Città #
Moscow 115
Singapore 112
Ashburn 47
Council Bluffs 45
San Jose 39
Hong Kong 38
Beijing 23
Dallas 23
Milan 22
Lauterbourg 17
New York 15
Santa Clara 14
Shanghai 14
Los Angeles 13
Orem 12
Boardman 11
Ho Chi Minh City 11
Nuremberg 11
Hanoi 10
Rome 10
Chicago 9
Hefei 9
Chennai 6
London 6
Cagliari 5
Helsinki 5
Mexico City 5
Montreal 5
Phoenix 5
São Paulo 5
Denver 4
Houston 4
Naples 4
Bari 3
Buffalo 3
Cesano Boscone 3
Cornaredo 3
Costa de' Nobili 3
Frankfurt am Main 3
Lappeenranta 3
San José 3
St Louis 3
Tokyo 3
Atlanta 2
Barnet 2
Bekasi 2
Bishkek 2
Brescia 2
Brooklyn 2
Calgary 2
Conway 2
Dublin 2
Edgewood 2
Falkenstein 2
Fucecchio 2
Jequié 2
Livorno 2
Oklahoma City 2
Ottawa 2
Paris 2
Pisa 2
Poplar 2
Porto Alegre 2
Queens 2
Toronto 2
Verona 2
Vinh 2
Warsaw 2
Wolfhagen 2
Addis Ababa 1
Aldie 1
Allentown 1
Amman 1
Amsterdam 1
Andradas 1
Angri 1
Annapolis 1
Apollo Beach 1
Araguaína 1
Arizona City 1
Aurora 1
Bakersfield 1
Bandaragama 1
Bauru 1
Bismarck 1
Biên Hòa 1
Bologna 1
Bolzano 1
Boydton 1
Brasília 1
Bratislava 1
Buena Fe 1
Byblos 1
Bắc Ninh 1
Cabo Frio 1
Cachoeirinha 1
Caicó 1
Cairo 1
Cali 1
Cape Town 1
Totale 787
Salva come PNG Salva come JPEG
Nome #
Management of Trastuzumab Deruxtecan-related nausea and vomiting in real-world practice 170
Completion Rate and Positive Results Reporting among Immunotherapy Trials in Breast Cancer, 2004-2023 119
Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response 114
Breast cancers with high proliferation and low ER-related signalling have poor prognosis and unique molecular features with implications for therapy 110
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer 106
Timing of Recurrence after Neoadjuvant Chemo-Immunotherapy in Patients with Early-Stage Triple-Negative Breast Cancer 102
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer 80
Neoadjuvant immunotherapy in triple-negative breast cancer: lesson learnt, remaining questions 64
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial 63
Personalized Risk–Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak 62
Immunotherapy in Breast Cancer Patients: A Focus on the Use of the Currently Available Biomarkers in Oncology 58
Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies 55
HER2-Low breast cancer: Pathological and clinical landscape 55
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis 48
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies 46
From intrinsic to adaptive clusters in breast cancer 40
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies 40
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer 37
Recent advances in triple negative breast cancer: The immunotherapy era 37
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer 36
Harmonizing gene signatures to predict benefit from adjuvant chemotherapy in early breast cancer 34
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials 34
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development 33
Profile of buparlisib and its potential in the treatment of breast cancer: Evidence to date 32
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review 29
The evolving landscape of ‘next-generation’ immune checkpoint inhibitors: A review 28
Development and validation of a gene expression-based Breast Cancer Purity Score 19
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer 16
Trastuzumab Biosimilars Setting the Pace for the Provision of a Cost Effective Oncological Care: Regulatory and Clinical Issues 16
De-escalation strategies for axillary management at primary surgery in early breast cancer: insights and implications for medical oncology practice 10
[18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial 5
Diagnostic accuracy of modern imaging following neoadjuvant therapy for breast cancer: a comparative analysis of ultrasound versus [18F] FDG PET/MRI in breast response assessment 5
Pan-cancer multi-omic integration of Trop2 reveals biological determinants and translational implications for ADC therapy 4
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 3
Totale 1.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20232 2 0 0 0 0 0 0 0 0 0 0 0
2023/202419 0 0 0 0 0 0 0 0 0 0 8 11
2024/2025207 29 11 3 14 19 29 28 30 14 8 8 14
2025/20261.314 37 44 21 70 87 118 104 146 474 92 58 63
2026/2027167 82 85 0 0 0 0 0 0 0 0 0 0
Totale 1.710